Position in ORGO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,754,558
+$17,910 QoQ
Shares Held
1,545,086
-2.0% QoQ
Ownership
1.20%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 134 holders
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $533,943,071 across 32 Drug Manufacturers - Specialty & Generic names. ORGO ranks #18 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
318,320 | $172,475,325 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
441,371 | $74,388,668 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
679,083 | $43,427,357 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
2,260,243 | $32,750,921 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
733,974 | $30,114,953 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,650,255 | $28,565,914 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
5,482,986 | $27,031,120 | |
| 8 | ZTS |
Zoetis Inc.
|
364,442 | $26,188,802 |
All Filings in ORGO
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,754,558 | 1,545,086 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $3,736,648 | 1,576,645 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $7,564,659 | 1,460,359 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $7,398,630 | 1,753,230 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $8,873,168 | 2,424,363 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $10,079,618 | 2,333,245 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $9,871,049 | 3,084,703 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $8,634,477 | 3,019,048 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $8,608,250 | 3,074,375 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $8,524,768 | 3,001,679 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $10,347,446 | 2,529,938 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $8,236,975 | 2,590,244 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,779,669 | 2,042,069 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $3,000,558 | 1,408,713 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $3,200,064 | 1,189,615 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,614,025 | 806,798 | Shares | Defined | 2022-11-14 | |
| 2021-12-31 | $24,024 | 2,600 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $2,817,754 | 197,876 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $2,201,036 | 132,433 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $629,355 | 34,542 | Shares | Defined | 2021-05-11 | |
| No filing history on record for this holder in this stock. | ||||||